| 2006-04-19 |
用於治療黃病毒科病毒感染之醫藥組合物、套組、及包裝產品 |
ZL03138694.6/2006-04-19 |
|
| 2006-02-09 |
Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: Design, synthesis, structural biology, and molecular docking studies |
Journal of Medicinal Chemistry. 2006 Feb;49(3):1212-1216. |
 |
| 2006-02 |
Stable RNA interference in Spodoptera frugiperda cells by a DNA vector-based method |
Biotechnology Letters. 2006 Feb;28(4):271-277. |
|
| 2006-01-01 |
Synthesis and anti-viral activity of a series of sesquiterpene lactones and analogues in the subgenomic HCV replicon system |
Bioorganic and Medicinal Chemistry. 2006 Jan 1;14(1):83-91. |
|
| 2006 |
Antiviral drug discovery targeting to viral proteases |
Current Pharmaceutical Design. 2006;12(11):1301-1314. |
|
| 2005-12-29 |
Novel indole-based peroxisome proliferator-activated receptor agonists: Design, SAR, structural biology, and biological activities |
Journal of Medicinal Chemistry. 2005 Dec;48(26):8194-8208. |
|
| 2005-11 |
Emergence of mutation clusters in the HCV genome during sequential viral passages in Sip-L expressing cells |
Journal of Virological Methods. 2005 Nov;129(2):170-177. |
|
| 2005-10 |
Inhibition of hepatitis C virus replication by antimonial compounds |
Antimicrobial Agents and Chemotherapy. 2005 Oct;49(10):4197-4202. |
|
| 2005-08-02 |
Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): Expression, purification, characterization, and inhibition |
Biochemistry. 2005 Aug;44(30):10349-10359. |
|
| 2005-08 |
High-throughput cell-based screening for hepatitis C virus NS3/4A protease inhibitors |
ASSAY and Drug Development Technologies. 2005 Aug;3(4):385-392. |
|
| 2005-06-05 |
High-efficiency protein expression mediated by enterovirus 71 internal ribosome entry |
Biotechnology and Bioengineering. 2005 Jun;90(5):656-662. |
|
| 2005-04-22 |
Anti-HCV activities of selective polyunsaturated fatty acids [Erratum: Biochemical and Biophysical Research Communications. 2004 May;318(1):275-280.] |
Biochemical and Biophysical Research Communications. 2005 Apr;329(4):1360. |
|
| 2005-03 |
Promazine analogues as potential anti SARS-CoV drugs |
Abstracts of Papers of the American Chemical Society. 2005 Mar;229(Part 2):U168. |
|
| 2005-03 |
Design, synthesis and sar of indole-based PPAR agonists |
Abstracts of Papers of the American Chemical Society. 2005 Mar;229(Part 2):U141. |
|
| 2005-03 |
Design and structure-activity relationships of novel indole-based PPAR agonists as antidiabetic agents |
Abstracts of Papers of the American Chemical Society. 2005 Mar;229(Part 2):U141. |
|
| 2005 |
Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3 '- digallate (TF3) |
Evidence-based Complementary and Alternative Medicine. 2005;2:209-215. |
|
| 2004-11-09 |
Anti-enterovirus compounds |
US6815444B2/2004-11-09 |
|
| 2004-10 |
Biosynthesis of human-type N-glycans in heterollogous systems |
Current Opinion in Structural Biology. 2004 Oct;14(5):601-606. |
|
| 2004-10 |
Emergence of mutation clusters in HCV genome during continuous passage of the virus in Sip-L expressing cells |
Hepatology. 2004 Oct;40(4):255A. |
|
| 2004-09-10 |
Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV |
FEBS Letters. 2004 Sep;574(1-3):116-120. |
|
| 2004-08 |
Inhibition of hepatitis C virus replication by arsenic trioxide |
Antimicrobial Agents and Chemotherapy. 2004 Aug;48(8):2876-2882. |
|
| 2004-07-23 |
Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate [Erratum: Biochemical and Biophysical Research Communications. 2004 Jun;318(4):862-867.] |
Biochemical and Biophysical Research Communications. 2004 Jul;320(2):623-623. |
|
| 2004-07 |
Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide |
Antimicrobial Agents and Chemotherapy. 2004 Jul;48(7):2693-2696. |
|
| 2004-06-11 |
Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate |
Biochemical and Biophysical Research Communications. 2004 Jun;318(4):862-867. |
|
| 2004-05-21 |
Anti-HCV activities of selective polyunsaturated fatty acids |
Biochemical and Biophysical Research Communications. 2004 May;318(1):275-280. |
|
